Next Article in Journal
Focus on Chemistry of the 10-Dioxane-nido-7,8-dicarba-undecahydrido Undecaborate Zwitterion; Exceptionally Easy Abstraction of Hydrogen Bridge and Double-Action Pathways Observed in Ring Cleavage Reactions with OH as Nucleophile
Next Article in Special Issue
Design, Synthesis, and Biological Evaluation of Aromatic Amide-Substituted Benzimidazole-Derived Chalcones. The Effect of Upregulating TP53 Protein Expression
Previous Article in Journal
Flavonoid Profile of the Genista tridentata L., a Species Used Traditionally to Treat Inflammatory Processes
Previous Article in Special Issue
Synthesis, Biological Assessment, and Structure Activity Relationship Studies of New Flavanones Embodying Chromene Moieties
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis of the Novel Covalent Cysteine Proteases Inhibitor with Iodoacetic Functional Group

by
Kinga Hartman
1,
Przemyslaw Mielczarek
1,2,* and
Jerzy Silberring
1
1
Department of Biochemistry and Neurobiology, Faculty of Materials Science and Ceramics, AGH University of Science and Technology, Mickiewicza 30, 30-059 Krakow, Poland
2
Polish Academy of Sciences, Maj Institute of Pharmacology, Laboratory of Proteomics and Mass Spectrometry, Smetna 12, 31-343 Krakow, Poland
*
Author to whom correspondence should be addressed.
Molecules 2020, 25(4), 813; https://doi.org/10.3390/molecules25040813
Submission received: 14 January 2020 / Revised: 7 February 2020 / Accepted: 12 February 2020 / Published: 13 February 2020
(This article belongs to the Special Issue New Studies on the Synthesis of Biologically Active Products)

Abstract

This work presents the synthesis of the novel covalent inhibitor of cysteine proteases where epoxide has been replaced by the iodoacetyl functional group. The molecule, similar in action to E-64 and DCG-04, the commonly applied inhibitors, is additionally biotinylated and contains tyrosyl iodination sites. The Fmoc solid phase synthesis has been applied. Conjugation of iodoacetic acid with the peptide was optimized by testing different conjugation agents. The purity of the final product was verified by mass spectrometry and its bioactivity was tested by incubation with a model cysteine protease—staphopain C. Finally, it was shown that the synthesized inhibitor binds to the protein at the ratio of 1:1. More detailed analysis by means of tandem mass spectrometry proved that the inhibitor binds to the cysteine present in the active site of the enzyme.
Keywords: iodoacetic acid; solid phase synthesis; DCG-04; inhibitor; cysteine protease iodoacetic acid; solid phase synthesis; DCG-04; inhibitor; cysteine protease
Graphical Abstract

Share and Cite

MDPI and ACS Style

Hartman, K.; Mielczarek, P.; Silberring, J. Synthesis of the Novel Covalent Cysteine Proteases Inhibitor with Iodoacetic Functional Group. Molecules 2020, 25, 813. https://doi.org/10.3390/molecules25040813

AMA Style

Hartman K, Mielczarek P, Silberring J. Synthesis of the Novel Covalent Cysteine Proteases Inhibitor with Iodoacetic Functional Group. Molecules. 2020; 25(4):813. https://doi.org/10.3390/molecules25040813

Chicago/Turabian Style

Hartman, Kinga, Przemyslaw Mielczarek, and Jerzy Silberring. 2020. "Synthesis of the Novel Covalent Cysteine Proteases Inhibitor with Iodoacetic Functional Group" Molecules 25, no. 4: 813. https://doi.org/10.3390/molecules25040813

APA Style

Hartman, K., Mielczarek, P., & Silberring, J. (2020). Synthesis of the Novel Covalent Cysteine Proteases Inhibitor with Iodoacetic Functional Group. Molecules, 25(4), 813. https://doi.org/10.3390/molecules25040813

Article Metrics

Back to TopTop